University of Tasmania
Browse

File(s) under permanent embargo

Idebenone treatment in Leber's hereditary optic neuropathy: rationale and efficacy

journal contribution
posted on 2023-05-22, 23:38 authored by Nuri GuvenNuri Guven, Faldu, D
Leber's hereditary optic neuropathy (LHON) is a rare mitochondrial retinopathy, caused by mutations in subunits of complex I of the respiratory chain, which leads to elevated levels of oxidative stress and an insufficient energy supply. This molecular pathology is thought to be responsible for the dysfunction and eventual apoptotic loss of retinal ganglion cells in the eye, which ultimately results in blindness. Many strategies, ranging from neuroprotectants, antioxidants, anti-apoptotic- and anti-inflammatory compounds have been tested with mixed results. Currently, the most promising compounds are shortchain quinones that have been shown to protect the vision of LHON patients during the early stages of the disease. This commentary gives a brief overview on the current status of tested therapeutics and also addresses future developments such as the use of gene therapy that hopefully will provide safe and efficient therapy options for all LHON patients.

History

Publication title

Expert opinion on orphan drugs

Issue

4

Pagination

130-135

ISSN

2167-8707

Department/School

School of Pharmacy and Pharmacology

Publisher

Informa Healthcare

Place of publication

UK

Repository Status

  • Restricted

Socio-economic Objectives

Expanding knowledge in the biological sciences

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC